1-Hydroxy-1h-1,2,3-benzotriazole-6-carboxylic acid, 95%, 50mg

1-(2,6-Dimethylphenyl)ethanone, 95.0%, 100g

2,6-Bis(4,5-dihydrooxazol-2-yl)pyridine, 95.0%, 10g

Methyl 5-amino-6-methoxypicolinate hydrochloride, 100mg

1'-(4-(1-(4-Fluorophenyl)-1H-indol-3-yl)butyl)-3H-spiro[isobenzofuran-1,4'-piperidine] hydrochloride, 98%, 50mg

Benzyl 5H,6H,7H,8H-imidazo[1,2-a]pyrazine-2-carboxylate dihydrochloride, 95%, 1g

3-(4-Chlorophenyl)-3-hydroxypropanenitrile, 98%, 500mg

8-tert-Butyl 3-ethyl 2,8-diazaspiro[4.5]decane-3,8-dicarboxylate, 95.0%, 5g

(4R,5R)-5-((R)-1,2-Dihydroxyethyl)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde, 95.0%, 250mg

Acetamidine Hydrochloride>95.0%(T)25g

Ácido levulínico, mínimo 98 %, para síntesis, 2,5 kg, envase de vidrio

2,6-Di(1H-benzo[d]imidazol-2-yl)pyridine, 95.0%, 250mg

5-Amino-4-methyl-1-phenyl-1,2-dihydro-pyrazol-3-one, 97%, 250mg